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Recently reports have indicated that both cimetidine and ranitidine delay cell proliferation in rats following 
7W/c partial hepatectomy and result in an increased mortality following this procedure. The present study was de-
signed to determine whether three Hz blocking agents (cimetidine, ranitidine, famotidine) and a new, powerful 
antisecretory drug (omeprazole) specifically influence hepatocyte proliferation in primary culture. Hepatocytes 
were isolated from livers of normal male rats by the standard collagenase perfusion technique. Hepatic DNA 
synthesis and percent of labelled nuclei were determined after 48 h incubation. Hepatocytes in culture were incu-
bated with the Hz blocking agents and omeprazole or with different concentrations of serum obtained from sham-
operated or 70% hepatectomized rats treated or not with the same agents. Rats were injected intraperitoneally 
at 8:00 a.m. on two consecutive days. In hepatectomized rats, the first dose was injected at 1'\:00 a.m. immediately 
after surgery, the second, 24 h later. The serum of sham-operated or 70O/C hepatectomized rats that did not re-
ceive drugs served as control. No changes in DNA synthesis, percentage of labelled nuclei and transaminase 
were detected when the agents were added to the hepatocytes in culture at concentrations within the effective 
pharmacological dosage and 30 times higher. Similarly, no changes in these parameters were obtained when dif-
ferent concentrations of serum obtained from sham-operated rats treated with Hz blocking agents or omeprazole 
were added to the basal culture medium. However, a significant inhibition of DN A synthesis and of percentage of 
labelled nuclei was observed when hepatocytes were incubated in the presence of serum from 70o/r hepatecto-
mized rats that had been treated with cimetidine or with ranitidine. The serum of 7fFX hepatectomized rats 
treated with famotidine and omeprazole had no effect on hepatocyte proliferation in vitro. No effect on trans-
aminase was found in these conditions. 
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H2 BLOCKING AGENTS AND REGENERATION 
Introduction 
It has recently heen reported that the administra-
tion of cimetidine and ranitidine to rats following 
70% partial hepatectomy (PH) significantly delays 
and inhibits hepatic DNA synthesis and the percent-
age of mitosis [1,2]. No direct evidence has been pre-
sented to explain the mechanism of this inhibition. 
Both these drugs continue to be widely used after ma-
jor hepatic resection for the prophylaxis of gastric 
complications ('stress ulcer syndrome ') [3-6] and are 
also widely prescribed to patients with chronic hep-
atic disorders and esophageal varices [7-9]. Thus, a 
more specific evaluation of the effect of these drugs 
on liver regeneration is warranted. 
The experiments reported here were designed to 
determine the effects of these compounds on hepato-
cyte proliferation in vitro. The two widely used 
agents, cimetidine and ranitidine, as well as a new, 
potent H" blocking agent, famotidine [10], and a new 
inhibitor of acid secretion, omeprazole [111, were 
evaluated. Either the antisecretory agents or the se-
rum taken from rats undergoing PH or sham opera-
tion and treated with these agents were tested. The 
H2 blocking agents and omeprazole were added di-
rectly to hepatocyte cultures in serum-free medium 
in the presence or absence of epidermal growth fac-
tor (EGF). 
Materials and Methods 
Animals 
Male Fischer F(344) rats, weighing ISO-200 g, 
were obtained from Hilltop Lab Animals, Inc., Scott-
dale, P A. The animals were housed in a temperature 
(20 ± I 0c) and light (6 a.m.-6 p.m.) controlled 
room and received food and water ad libitum. Seven-
ty percent PH was performed according to the meth-
od described by Higgins and Anderson [12]. Sham 
operation consisted of a laparotomy and gentle man-
ual manipulation of the liver. All surgical procedures 
were performed between 7:30 and 9:00 a.m. 
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Materials 
Collagenase type I (125-250 U/mg) was purchased 
from Worthington Diagnostic Systems, Freehold, 
NJ. MEM (minimal essential medium) and fetal calf 
serum (FCS) were purchased from GIBCO Labora-
torics, Grand Island, NY. Insulin, EGF, HEPES, py-
ruvic acid and proline were purchased from Sigma 
Chemical Company, St. Louis, MO. [methYPH]-
Thymidine (50-SO Ci/mmol) was purchased from 
New England Nuclear, Boston, MA. Cimetidine was 
obtained from Smith, Kline and French Lab Co., 
Caroline, PR, ranitidine from Glaxo, Inc., Research 
Triangle Park, NC, famotidine from Sigma Tau Co., 
Rome, Italy, omeprazole from Bracco, Milan, Italy. 
Aqueous Counting Scintillant (ACS) was purchased 
from Amersham, Arlington Heights, IL. 
Isolation of hepatocytes 
Hepatocytes were isolated from 7-week-old male 
rats weighing lS0-200 g, by a modification of the in 
situ two-step collagenase perfusion technique of Seg-
len [13] described by lirtle et al. [14]. The liver was 
perfused via a cannula in the inferior vena cava with 
250 ml buffer (142 mM NaCl, 6.7 mM KCI, 10 mM 
HEPES, pH 7.4) followed by 250 ml of the same buf-
fer containing in addition 5.7 mM CaCl2 and 0.5 
mg/ml collagenase. The hepatocytes were dispersed 
and washed twice with cold Ca2+ -free perfusion buf-
fer and resuspended in MEM supplemented with 
proline (26 mM), pyruvate (1 mM), aspartate (0.2 
mM), serine (0.2 mM), gentamycin (40,ug/ml). For 
attachment, insulin (10-7 M) and FCS (5%) were 
added. Viability was determined by trypan blue ex-
clusion [15] and only preparations having greater 
than 90% viability were used. Cell number was de-
termined with a hemocytometer. 
The cells were plated at a cell density of 2 x 105 in 
35-mm Falcon 'Primaria' tissue culture dishes in 1.5 
ml medium and maintained at 37°C and at 5% CO2 
atmosphere. Following a 3-h attachment period, 
MEM was added with the specified additions as re-
ported. EGF and insulin, when added, were at a con-
centration of 10 ng/ml and 10-7 M. respectively. 
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Determination of r'Hjthymidine incorporation and 
DNA synthesis 
After a 3-h period, necessary for the hepatocyte 
attachment, the medium was changed and specific 
additions were made. [3H]Thymidine, 7.5 ,uCi/dish, 
was present from 24-48 h or from 48-72 h. Each ex-
perimental group comprised four dishes. When the 
cells were harvested, two dishes were used to deter-
mine DNA content using the microfluorometric 
method of Setaro and Morley [16], and two dishes of 
each group were treated as described by Michalo-
poulos et al. [17] to measure [3H]thymidine incorpo-
ration. 
Serum studies 
Forty normal rats were sham-operated, divided 
into five groups and injected as follows: group 1, ci-
metidine (2.4 mgl200 g hody wt.); group II, raniti-
dine (0.8 mg/200 g body wt.): group Ill, famotidine 
(0.11 mg/200 g body wt.); group IV, omeprazole 
(0.06 mg/200 g body wt.); group V, saline. Another 
40 rats underwent PH, were divided into five groups 
and injected in the same manner as the sham group. 
All animals were operated on before 8 a.m. and all 
were injected i.p. at 8 a.m. on the day of operation 
and at 8 a.m. the following day with the drugs dis-
solved in saline (0.5 ml) with the exception of ome-
prazole which was dissolved in PEG-500. Under 
ether anesthesia, blood was taken from the animals 3 
h after the final injection. Blood samples of these ani-
mals. as well as blood taken from a group of eight 
normal unhepatectomized rats. were taken for hor-
monal study. 
Alltoradiography 
For autoradiographic studies, hepatocytes plated 
on 'Primaria' dishes were fixed and stained for glu-
cose-6-phosphate dehydrogenase directly on the 
dishes, as reported by us [18]. [3H]Thymidine. 7.5 
,uCi/dish, was present for 24 h prior to fixation. The 
dishes were covered with emulsion (Kodak NTB3) 
and developed after 10 days. The labelling index was 
determined by counting a total of 1000 cells per dish. 
The glucose-6-phosphate dehydrogenase positivity 
clearly showed that the cultured cells were parenchy-
mal hepatic cells [18]. 
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Hormone studies 
The plasma levels of immunoreactive insulin (IRI) 
were determined by radioimmunoassay using an in-
sulin kit obtained from Serono Diagnostics (Brain-
tree, MO). The detection limit of the assay was 5 
,uU/ml. 
The plasma levels of immunoreactive glucagon 
(IRG) were determined with a glucagon kit obtained 
from Serono Diagnostics. This kit was specifically 
chosen for its high degree of accuracy, precision and 
specificity as has been reported [19,20]. Samples for 
the glucagon assay were collected in chilled tubes 
containing 500 units of a trypsin inhibitor (aprotinin) 
and 1.2 mg of sodium EDT Alml of whole blood col-
lected for assay. The detection limit for the assay was 
15 pg/ml. The results were also expressed as insu-
lin/glucagon molar ratio which was calculated as sug-
gested by Muller [21] using the formula [IRI (,u U! 
ml)/IRG (pg/ml)] x 23.33 = ratio. This formula as-
sumes that insulin has a molecular weight of 6000 Da 
and a biologic activity of 25 units/mg. It also assumes 
that glucagon has a molecular weight of 3500 Da. Se-
rum testosterone and estradiol were determined by 
specific radioimmunoassays as described previously 
[22]. 
Cimetidine determination 
The blood level of cimetidine was determined with 
HPLC using the method of Mihaley et al. [23]. Blood 
was taken under ether anesthesia from three untreat-
ed sham and PH rats (control). nine sham-operated 
and nine PH rats treated with cimetidine as reported 
in Materials and Methods. In the untreated rats, the 
blood was taken at 8 a.m. and used as a control. In 
the sham-operated and the PH operated rats (three 
from each group), blood was taken 1, 2 and 3 h after 
the last injection of cimetidine on the second day of 
treatment. 
Determination of aminotransferases in the medium 
Hepatocytes were seeded as described above, and 
test compounds were added 3 h later (first medium 
change) at the concentrations indicated in Table 1. 
The medium, after 48 h of incubation, was centri-
fuged at 2000 x g for 15 min, and an aliquot of the su-
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pernatant was diluted with an equal volume of phos-
phate-buffered saline. Activity of alanine amino-
transferase (ALT) (EC 2.6.1.2) was determined with 
a spectrophotometer (Perkin-Elmer Coleman 124D, 
Maywood, IL) by the lactate dehydrogenase cou-
pling method as originally described by Karmen 
[24,25]. The activities of transaminase in the medium 
are expressed in U/mi. One unit of activity is defined 
as the amount of enzyme, which produces l.umol of 
NAD per min under the conditions of the assay pro-
cedure. 
Statistical study 
The unpaired Student's (-test was used for statis-
tical analysis of the data using the program available 
on the Hewlett-Packard 9815S (Hewlett-Packard 
Co., Palo Alto, CA). 
Results 
Table 1 demonstrates the results of cimetidine, ra-
nitidine, famotidine, omeprazole and saline treat-
ment on the viability, DNA, and AL T of hepatocytes 
in primary cultures. As is reported in our previous 
paper [18], 98% of cells attached to the dish were 
TABLE 1 
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hepatocytes. The H2 blocking agents were added to 
hepatocytes cultured in serum-free medium in the 
presence of insulin alone (10-7 M). This medium is 
optimal for preserving all the metabolic properties of 
hepatocytes without promoting proliferation. More-
over, it is ideal for metabolic as well as toxicological 
studies. The drug concentrations listed in Table 1 are 
30 times higher than the maximum concentration 
found in the blood of patients and animals treated 
with a single therapeutic dose of H2 blockers [26-29]. 
There were no significant differences in the viability 
or DNA concentration of hepatocytes and trans-
aminase in the medium in the presence or absence of 
the H2 blocking agents and omeprazole, suggesting 
that these drugs have no direct toxic effect on hepato-
cytes in culture. 
Fig. 1 depicts the effect of various concentrations 
of cimetidine, ranitidine, famotidine and omeprazole 
on the proliferation of hepatocytes cultured for 48 h 
in serum-free medium. Conditions were the same as 
in the previous experiment, with the exception of an 
addition of EGF to the medium which promoted hep-
atocyte proliferation. None of these drugs affected 
the hepatocyte proliferation stimulated by EGF. Fur-
ther confirmation of these results is reported in Table 
2, which lists the concentration of DNA and the per-
EFFECT OF CIMETIDINE, RANITIDINE, FAMOTIDINE AND OMEPRAZOLE ON VIABILITY, DNA CONCENTRA-
TION AND TRANSAMINASE LEVELS OF HEPATOCYTES IN 'PRIMARY CULTURES' 
Hepatocyte isolation has been described under 'Materials and Methods'. Cells were plated in MEM supplemented with 5% FCS and 
insulin (10-7 M). After 3 h attachment, the medium and floating cells were removed and serum-free MEM plus insulin (10-7 M) was 
added. Antisecretory agents were added as indicated. Cells were cultured for 72 h and processed every 24 h for viability and DNA de-
terminations. AL T was determined and expressed as U/ml only for the dishes stopped after 72 h of incubation. For each time point, 
triplicate culture dishes were assayed. The results are expressed as the average from 9 dishes and 3 different animals (mean ± S.D.). 
24h 48h 
Viability DNA Viability 
(%) (ug/dish) (%) 
Control 95 ± 3 3.2 ± 0.2 97 ± 3 
Cimetidine 97 ± 2 3.1 ± 0.2 98 ± 2 
27 x 10-6 g/ml 
Ranitidine 98 ± 1 3.1 ± 0.3 97 ± 3 
6.0 x 10-6 g/ml 
Famotidine 95 ± 2 3.2 ± 0.1 96 ± 1 
2.1 x 10-6 g/ml 
Omeprazole 95 ± 1 3.2 ± 0.1 97 ± 2 
1.8 x 10-6 g/ml 
72h 
DNA Viability 
(ug/dish) (%) 
3.3 ± 0.2 98 ± 2 
3.2 ± 0.3 98 ± 1 
3.4 ± 0.35 96 ± 4 
2.95 ± 1.2 97 ± 1 
2.9 ± 1.1 97 ± 2 
DNA 
(ug/dish) 
3.28 ± 0.3 
3.28 ± 0.2 
3.05 ± 0.4 
3.08 ± 0.7 
3.3 ± 0.9 
ALT(U/ml) 
9±3 
11 ± 5 
10 ± 9 
12 ± 3 
8±2 
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Fig. 1. Effect of cimetidine, ranitidine, famotidine and omepra-
zoic on DNA synthesis of hepatocytes in primary culture. Hep-
atocyte isolation has been described under 'Materials and 
Methods'. Cells wefe plated in MEM supplemented with 5% 
FCS and insulin (10- 7 M). After 3 h, the medium and floating 
cells were discarded and serum-free medium plus insulin (10-7 
M), EGF (10 ng/ml) and proline (0.26 mM) were added. H2 
blocking agents were added at different concentrations on the 
basis of their blood level after administration of a therapeutic 
dose: cimetidine, ranitidine, famotidine (0.62-30 ,ug/ml) and 
omeprazole (0.06-/.8 ,ug/ml). Cultures were exposed to 7.5 
.uCi eH]thymidine for the last 24 h and processed after 48 h for 
determination of DNA synthesis. For each medium, triplicate 
culture dishes from 5 different animals were used. Results 
(mean ± S.D.) are expressed as cpm x 1O-21,ug DNA. 
cent labelled nuclei index of hepatocyte prolifer-
ation. This stimulation of hepatocyte proliferation 
over that observed in the culture incubated in the 
presence of insulin alone was not affected by the 
presence of drugs. The same results were obtained 
when, under the same conditions, serum of PH or 
non-PH rats was added. Fig. 2 outlines the effect of 
various serum concentrations (IO-S0o/r) final concen-
tration) on the DNA synthesis of hepatocytes in cul-
ture. Serum was obtained from sham-operated ani-
mals which had received i.p. cimetidine, ranitidine, 
famotidine, omeprazole and saline. No statistical dif-
ference was found in DNA synthesis between any of 
these groups. The effect of serum, obtained from rats 
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TABLE 2 
DNA CON CENTRA TION AND LABELLING INDEX OF 
HEPATOCYTE CULTURES GROWN IN THE PRES· 
ENCE OF CIMETIDINE, RANITIDINE, FAMOTIDINE, 
AND OMEPRAZOLE 
Culture conditions were as for Fig. 1. After 48 h of incubation, 
dishes were processed for DNA concentration and % labelled 
nuclei. Concentrations of H2 blocking agents were 30 times 
higher than the blood value found in patients injected with one 
pharmacological dose of the drugs. Cultures without H2 block· 
ing agents were used as control. DNA concentration was ex-
pressed as ,ug/dish. The results are expressed as the average 
from 9 dishes and 3 different animals (mean ± S.D.). DNA in 
the labelled nuclei of hepatocytes incubated in the presence of 
insulin alone was 2.8 ± 0.33 ,ug/dish; percent of labelled nuclei 
in the same conditions was 4.5 ± 7. 
DNA (,ug/dish) Labelled nuclei (%) 
Control (saline) 6.2 ± 1.2 10 ± 1 
Cimetidine 5.2 ± 1.8 9±2 
27 x 10-6 g/ml 
Ranitidine 5.8 ± 1.2 10 ± 2 
6.0 x 10-6 glml 
Famotidine 5.5 ± 2.0 12 ± 2 
2.1 x 10-6 g/ml 
Omeprazole 5.9 ± 1.8 11 ± 3 
1. 8 X 10-6 g/ml 
that underwent PH and received H2 blocking agents 
and omeprazole, on DNA synthesis and percentage 
of labelled nuclei is depicted in Fig. 3. The DNA syn-
375 
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Fig. 2. Effect of serum obtained from rats sham-operated and 
treated with H2 blocking agents and omeprazole on DNA syn· 
thesis of hepatocytes in primary culture. The experimental con-
ditions are described in 'Materials and Methods'. Culture con· 
ditions were as in Fig. 1, with the exception that serum from 
rats treated with or without (as control) H2 blocking agents 
were added instead of EGF. Four concentrations (10-50%) of 
serum were used. Results (mean ± S.D.) are expressed as cpm 
x 1O-21,ug DNA. For each medium, triplicate culture dishes 
from 5 different experiments were used. 
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Fig. 3. Effect of different concentrations of serum obtained 
from 70% hepatectomized rats treated or not with cimetidine, 
ranitidine, famotidine and omeprazole on DNA synthesis, % 
labelling index and AL T of hepatocytes in primary culture. The 
experimental conditions are described in 'Materials and Meth-
ods'. Culture conditions were as reported in Fig. 1, with the ex-
ception that serum from treated and not treated (as control) 
70% hepatectomized rats was added instead ofEGF. Four final 
concentrations (10, 20, 40 and 50%) of serum were used. Expo-
sure to [3H]thymidine was for 24 h. Individual culture dishes 
were processed for autoradiography and DNA synthesis. A to-
tal of 1000 cells randomly selected were counted to obtain the 
percent oflabelled cells. Results are presented as mean ± S.D. 
(DNA synthesis = cpm x 1O-2/,ug DNA; labelled nuclei = % of 
labelled nuclei; aminotransferase = Vlml). For each medium, 
triplicate culture dishes from 5 different experiments were 
used. Significantly different from the control value observed in 
each group: • P < 0.05; •• P < 0.01. 
thetic activity of hepatocytes cultured in the presence 
of different concentrations of serum from hepatecto-
mized rats treated with the drugs was compared with 
the values obtained using the serum from hepatecto-
mized rats treated with saline. The serum of PH rats 
treated with cimetidine inhibited DNA synthesis and 
percent of labelled nuclei at all the concentrations of 
serum used. Although the inhibitory effect of cimeti-
dine was partially covered by the different serum 
concentrations, the percent of the effect increased in 
relation to the amount of serum used (10% serum = 
37 
29% inhibition; 40% serum = 38% inhibition). The 
serum of PH rats injected with ranitidine inhibited 
hepatocyte proliferation only at the higher serum 
concentrations, i.e., 40-50%. No inhibitory effects 
were observed using the serum of PH animals treated 
with famotidine or omeprazole. The figure also 
shows the value of ALT in these conditions. No sig-
nificant variation of ALT was observed in the pres-
ence of 40% serum concentrations . 
Table 3 reports the values of glucagon, insulin, in-
sulin/glucagon ratio, estrogen and testosterone in 
sham-operated rats and in rats who underwent a 70% 
PH 24 h before, treated and not treated with antise-
cretory substances. The significant variation due to 
the surgical procedures (P < 0.05) for insulin, gluca-
gon and testosterone was not affected by the adminis-
tration of H2 blocking agents or omeprazole. The 
hormonal determinations were done in five animals 
of each group. 
Fig. 4 reports the level of cimetidine in sham-oper-
ated and PH rats treated with cimetidine as is re-
ported in Materials and Methods. Cimetidine was not 
found in the blood of untreated sham and PH rats. 
Sham-operated treated rats have high blood levels of 
cimetidine 1 h after its administration, which de-
creases over a period of 3 h. In contrast, the blood 
level of cimetidine in PH-treated rats remained con-
stant over the same period. We only studied the lev-
els of cimetidine in these experiments since it demon-
strated the most significant effect on regeneration. 
We did not measure cimetidine level immediately af-
ter surgery to avoid any influence of surgical stress 
and/or anesthesia in drug kinetics. 
Discussion 
Two commonly used H2 blocking agents, cimeti-
dine and ranitidine, have been demonstrated recent-
ly to interfere significantly with DNA synthesis in a 
model of 70% partially hepatectomized rats [1,2]. 
Although the change (hemodynamics) produced by 
these agents was ruled out as a possible mechanism of 
action [2], no further attempts to define the basis of 
this observation have been reported. It is now well 
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TABLE 3 
DETERMINATION OF INSULIN. GLUCAGON, IRIIIRG, ESTROGEN AND TESTOSTERONE Il'i SHAM-OPERATED 
RATS AND Tl'i PH RATS TREATED IN OUR STUDY WITH H, BLOCKING AGENTS OR OMEPRAZOLE 
---- ---
Glucagon Insulin IRJlIRG Estrogen Testosterone 
(pg/ml) (aU/ml) (pg/ml) (ng/ml) 
-----
Sham rats 
control 180 ± 56 27 ± 2 3.50 8.3 ± 3 1.7 ± 0.33 
cimetidine 173 ± 68 24 ± 3 3.23 7.3 ± 2 1.3 ± 0.35 
ranitidine 183 ± 22 18 ± 7 2.29 3.5 ± 5 1.4 ± 0.15 
famotidine 198 ± 64 28 ± 2 3.29 10.3 ± 4 1.5 ± 0.40 
omeprazolc 193 ± 85 25 ± 3 4.10 6.4 ± 3 2.0 ± 0.50 
700/c PH rats 
control 410 ± 110 20 ± 2.0 1.14 7.9±2.1 0.30 ± 0.03 
cimetidine 460 ± ISO 24 ± 2.4 1.20 7.8 ± 3.0 0.95 ± 0.01 
ranitidine 540 ± 100 29 ± 3.0 1.25 6.9 ± 4.0 O.IS ± 0.02 
famotidine 480 ± 90 26 ± 1.5 1.26 9.3 ± 3.0 0.32 ± 0.03 
omeprazok 420 ± 70 27 ± 7.2 1.50 8.1±2.0 O.4S ± 0.04 
Control, saline; cimetidinc, 2.4 mg/rat; ranitidine. 0.8 mglrat; famotidine. 0.11 mglrat; omeprazole, 0.06 mglrat. 
established that hepatocytes in culture with serum-
supplemented or serum-free medium can be main-
tained for several days and can be induced to synthe-
size DNA by providing certain hormones or growth 
factors [15,18,30-33]. This represents a model in vi-
tro system to evaluate candidates which are proposed 
to interfere with hepatocyte proliferation. This sys-
tem has been used in the present studies as the basis 
for defining the effect of three H2 blocking agents (ci-
metidine, ranitidine, famotidine) and a gastric secre-
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Fig. 4. Cimetidine levels in sham-operated (_____.e) and PH 
(0- - -0) rats. 
tion inhibitory agent (omeprazole). 
The results reported here clearly demonstrate that 
first- (cimetidine and ranitidine) and second (famoti-
dine)-generation H;, blocking agents and omeprazole 
do not exert any measurable direct control on hep-
atocyte proliferation in vitro. The addition of these 
agents, also when used at very high concentrations 
(30 times the active pharmacological dose found in 
the blood of patients treated with a single therapeutic 
dosage of the drugs), does not affect the viability, the 
DNA content or the proliferating activity of hepato-
cytes maintained in primary culture for a period of 
72 h. 
To further define their possible influence on hep-
atocyte proliferation, the effect of serum obtained 
from rats treated with H2 blocking agents or omepra-
zole was studied. Two sets of experiments were com-
pared, one using the serum of sham-operated ani-
mals, the other using serum of 70% hepatectomized 
rats. The most significant results were observed 
when the serum of 70% hepatectomized rats treated 
with the drugs was added to the culture medium (Fig. 
3). Serum from hepatectomized rats treated with ci-
metidine inhibited hepatic proliferation in a manner 
that was somewhat related to the concentration of se-
rum used. Serum of PH animals treated with raniti-
dine resulted in inhibition of DNA synthesis only at 
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very high concentrations, while the serum of PH ani-
mals treated with famotidine and omeprazole did not 
affect hepatic proliferation at any of the concentra-
tions used. It is evident from these studies, therefore, 
that the significant inhibition of DNA synthesis and 
percent labelled nuclei that is modulated by cimeti-
dine and ranitidine is not due to the actual drug but is 
manifested by their ability to induce some varia-
tion(s) in the composition of serum during the course 
of hepatic regeneration. 
Many recent investigations and reviews have fo-
cused on the permissive effect, or possibly the initiat-
ing role, of hormones in hepatic regeneration 
[34-36]. Insulin and glucagon were the first two hor-
mones whose so-called hepatotrophic action was as-
sociated with liver regeneration [37,38]. Since then. 
manv studies have shown that other hormonal 
changes, especially those related to sex hormones. 
occur during the first 48 h of liver regeneration 
[39-491· 
On the other hand, the ability of H2 blocking 
agents to interfere with the hormonal state has been 
well known since the beginning of the clinical use of 
cimetidine [50]. Variations of the hypothalamic-pitu-
itary-gonadal axis have been reported during treat-
ment with cimetidine which have been associated 
with increased serum prolactin levels, impotence and 
gynecomastia [51,52]. 
Only a few reports regarding these effects are de-
scribed for ranitidinc [51-54] while none have been 
reported for famotidine or omeprazole [55]. The data 
reported here demonstrate that insulin and glucagon 
as well as estrogen and testosterone blood levels do 
not change in the PH animal despite the treatment 
regimen imposed on the rats. Therefore, the inhibito-
ry effect on hepatic proliferation is not due to the hor-
monal changes measured in these studies in the se-
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